SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)
Description
This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.
Resources
| Name |
Format |
Description |
Link |
| SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) |
HTML |
|
https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/novel-coronavirus-january-27.html |
| SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/biosecurite-biosurete-laboratoire/directives-avis-avis-speciaux-matiere-biosecurite/nouveau-coronavirus-27-janvier.html |